May. 07, 2014News & Opinions
As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in the second half of 2014.
Apr. 23, 2014News & Opinions
Novartis and GlaxoSmithKline have announced an asset swap worth more than $20 billion, with an eye to bolstering their best businesses and exiting weaker ones.
Apr. 15, 2014News & Opinions
GlaxoSmithKline (GSK) is facing fresh allegations of corruption, following reported incidents in China and Iraq. Polish authorities have launched a criminal investigation against the UK's biggest drugmaker for allegedly bribing doctors to ...
Apr. 11, 2014News & Opinions
U.S. biotechnology firm Amgen, the world's largest, is ending its agreement with the U.K. drugmaker GlaxoSmithkline for the marketing of its osteoporosis drug in some regions outside the U.S..
Apr. 10, 2014News & Opinions
U.K. drugmaker GlaxoSmithKine (GSK), already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the company has confirmed.
Mar. 28, 2014News & Opinions
GlaxoSmithKline (GSK), the UK's largest pharmaceutical company, has provisionally withdrawn its marketing authorization application to the European Medicines Agency (EMA) for the combined use of Tafinlar (also known as dabrafenib, ...
Mar. 12, 2014News & Opinions
British drugmaker GlaxoSmithKline (GSK) said it has successfully increased its stake in its publicly-listed Indian pharmaceuticals subsidiary GlaxoSmithKline Pharmaceuticals Limited from 50.7% to 75%. The Indian firm will remain ...
Feb. 21, 2014News & Opinions
A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people familiar with the matter told the news agency Reuters.
Dec. 19, 2013News & Opinions
UK drugmaker Glaxo SmithKline has said it would cease offering financial incentives to doctors to promote its products through speaking engagements, for example. The company also will stop linking remuneration of its sales representatives ...
Dec. 03, 2013News & Opinions
British Prime Minister David Cameron raised GlaxoSmithKline's problems in China - where it is being investigated for alleged bribery - with political leaders on Monday as the drugmaker emphasized its commitment to doing business there.
The latest information directly via newsletter.